Table 1.
Population demographics by cohort
|
All (Full cohort) (n=7622) N (column %) |
PROMISE (n=2211) |
MGB BB (n=5411) |
||
|---|---|---|---|---|
| Race | ||||
| Black | 2439 (32%) | 187 (8%) | 2252 (42%) | |
| White | 4986 (65%) | 1941 (88%) | 3045 (56%) | |
| Other | 119 (2%) | 64 (3%) | 55 (1%) | |
| Unknown | 78 (1%) | 19 (1%) | 59 (1%) | |
| Gender | ||||
| Female | 5013 (66%) | 1594 (72%) | 3419 (63%) | |
| Male | 2570 (34%) | 578 (26%) | 1992 (37%) | |
| Unknown | 39 (<1%) | 39 (2%) | 0 (0%) | |
| Age at screening | ||||
| Median (IQR) | 56.0 years (IQR: 45.8–64.1) | 58.8 years (IQR: 51.1–65.0) | 54 years (IQR: 42–64) | |
| Age class at screening | ||||
| 18–29 | 373 (5%) | 2 (<1%) | 371 (7%) | |
| 30–39 | 774 (10%) | 10 (<1%) | 764 (14%) | |
| 40–49 | 1417 (19%) | 466 (21%) | 951 (18%) | |
| 50–59 | 2086 (27%) | 710 (32%) | 1376 (25%) | |
| 60–69 | 2026 (27%) | 772 (35%) | 1254 (23%) | |
| 70–79 | 774 (10%) | 215 (10%) | 559 (10%) | |
| 80–89 | 130 (2%) | 2 (<1) | 128 (2%) | |
| 90+ | 8 (<1%) | 0 (0%) | 8 (<1%) | |
| Unknown | 34 (<1%) | 34 (2%) | 0 (0%) | |
| Charlson Comorbidity Index* | ||||
| 0 | 558 (10%) | N/A | 558 (10%) | |
| 1 | 542 (10%) | N/A | 542 (10%) | |
| 2 | 537 (10%) | N/A | 537 (10%) | |
| 3 | 599 (11%) | N/A | 599 (11%) | |
| 4 | 533 (10%) | N/A | 533 (10%) | |
| 5 | 474 (9%) | N/A | 474 (9%) | |
| 6 | 405 (8%) | N/A | 405 (8%) | |
| 7+ | 1746 (32%) | N/A | 1746 (32%) | |
| Missing | 2228 | 2211 | 17 | |
| *Charlson index is missing for the PROMISE cohort | ||||
| Risk Category | ||||
| Black or African-American | 2439 (32%) | 187 (8%) | 2252 (42%) | |
| Non-Black w/ + Family History | 3866 (51%) | 2024 (92%) | 1842 (34%) | |
| Non-Black w/ no Family History | 631 (8%) | 0 (0%) | 631 (12%) | |
| Non-Black, Unknown if family history | 686 (9%) | 0 (0%) | 686 (13%) | |